Balucan, Visitacion .

HRN: 23-98-58  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/26/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/26/2023
10/31/2023
IV
1.5g
BID
Infected Wound
Waiting Final Action 
10/26/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/26/2023
10/31/2023
IV
300mg
QID
Infected Wound
Waiting Final Action 
10/27/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/27/2023
11/23/2023
IV
1.5g
Q8
Infected Wound
Waiting Final Action 
10/27/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/27/2023
11/22/2023
IV
600mg
Q6
Infected Wound
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: